UNRESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Clinical trials for UNRESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy-Chemo combo shows promise in advanced sarcoma trial
Disease control Recruiting nowThis study tests whether adding an immunotherapy drug (pembrolizumab) to standard chemotherapy (doxorubicin) helps people with certain advanced sarcomas live longer without their cancer growing. The trial includes about 365 adults whose sarcoma has spread or cannot be removed by …
Matched conditions: UNRESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:37 UTC
-
New hope for rare sarcomas: drug combo enters human testing
Disease control Recruiting nowThis early-phase trial tests a new two-drug combination for people with advanced soft tissue sarcomas that have spread or can't be removed by surgery. The study combines a standard chemotherapy (liposomal doxorubicin) with an experimental drug (peposertib) that may help the chemo…
Matched conditions: UNRESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:37 UTC